- Home
- IMNN vs OSRH Comparison
IMNN vs OSRH Comparison
Compare IMNN & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- OSRH
- Stock Information
- Founded
- IMNN 1982
- OSRH N/A
- Country
- IMNN United States
- OSRH United States
- Employees
- IMNN N/A
- OSRH N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- OSRH
- Sector
- IMNN Health Care
- OSRH
- Exchange
- IMNN Nasdaq
- OSRH Nasdaq
- Market Cap
- IMNN 12.1M
- OSRH 11.1M
- IPO Year
- IMNN 1985
- OSRH N/A
- Fundamental
- Price
- IMNN $5.75
- OSRH $0.62
- Analyst Decision
- IMNN Buy
- OSRH
- Analyst Count
- IMNN 2
- OSRH 0
- Target Price
- IMNN $182.61
- OSRH N/A
- AVG Volume (30 Days)
- IMNN 55.7K
- OSRH 13.9M
- Earning Date
- IMNN 11-06-2025
- OSRH 08-14-2025
- Dividend Yield
- IMNN N/A
- OSRH N/A
- EPS Growth
- IMNN N/A
- OSRH N/A
- EPS
- IMNN N/A
- OSRH N/A
- Revenue
- IMNN N/A
- OSRH $104,735.00
- Revenue This Year
- IMNN N/A
- OSRH N/A
- Revenue Next Year
- IMNN N/A
- OSRH N/A
- P/E Ratio
- IMNN N/A
- OSRH N/A
- Revenue Growth
- IMNN N/A
- OSRH N/A
- 52 Week Low
- IMNN $4.83
- OSRH $0.45
- 52 Week High
- IMNN $41.22
- OSRH $13.40
- Technical
- Relative Strength Index (RSI)
- IMNN 36.86
- OSRH 45.01
- Support Level
- IMNN $5.53
- OSRH $0.57
- Resistance Level
- IMNN $5.89
- OSRH $0.62
- Average True Range (ATR)
- IMNN 0.32
- OSRH 0.10
- MACD
- IMNN 0.07
- OSRH 0.00
- Stochastic Oscillator
- IMNN 23.81
- OSRH 10.81
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.